PReP hiv injectable

FDA says injectable PrEP a ‘breakthrough’ therapy as it pends approval

Related: Long-acting PrEP injections show some benefits over daily tabletsOne recent study, published in July, found the injectable PrEP to be 66% more effective at reducing HIV transmission.

That study specifically looked at 4,500 transgender women and cisgender gay men who had sex with men.When taken as directed, daily PrEP medication is highly effective at preventing someone from acquiring HIV.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News